Key Details
Price
$1.29Annual ROE
-12.25%Beta
1.02Events Calendar
Next earnings date:
Aug 29, 2025Recent quarterly earnings:
Aug 29, 2024Recent annual earnings:
Mar 31, 2023Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Apr 08, 2021Analyst ratings
Recent major analysts updates
Screeners with INCR included
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
InterCure Ltd. INCR has shown resilience in its H1 2024 performance despite facing significant challenges, according to equity research by Pablo Zuanic of Zuanic & Associates.
NEW YORK and HERZLIYA, Israel, Aug. 29, 2024 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TASE: INCR) ("InterCure" or the "Company") is pleased to announce its financial and operating results for the six months ended June 30, 2024. All amounts are expressed in New Israeli Shekels (NIS), unless otherwise noted.
InterCure is a leading pharmaceutical/medical cannabis company based in Israel and a global leader outside North America. Despite the damage the Hamas attack and the state of war in Israel caused, the company managed to sustain operations and present a positive 2023 ER. The company is entitled to full compensation from the Israeli government for the damage taken.
NEW YORK & HERZLIYA, Israel--(BUSINESS WIRE)--InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc), the leading medical cannabis company outside of North America, today announced that it will participate in the Canaccord Genuity 8th Annual Global Cannabis Conference. The conference is scheduled for tomorrow, May 23, 2024, at the Westin NY Grand Central Hotel in New York City. This prestigious event will bring together senior management teams from leading cannabis companies including InterCu.
InterCure Ltd. (NASDAQ:INCR ) Q4 2022 Earnings Conference Call April 4, 2023 4:30 PM ET Company Participants Alexander Rabinovitch - CEO & Director Amos Cohen - CFO Conference Call Participants Vivien Azer - Cowen and Company Matt Bottomley - Canaccord Genuity Pablo Zuanic - Zuanic & Associates Operator Thank you for standing by, and welcome to InterCure's Fourth Quarter 2022 Earnings Call.
NEW YORK, TORONTO, and HERZLIYA, Israel, April 03, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) announced today that it has rescheduled its previously announced conference call to discuss the company's financial results for the full year ended December 31, 2022.
FAQ
- What is the primary business of InterCure?
- What is the ticker symbol for InterCure?
- Does InterCure pay dividends?
- What sector is InterCure in?
- What industry is InterCure in?
- What country is InterCure based in?
- When did InterCure go public?
- Is InterCure in the S&P 500?
- Is InterCure in the NASDAQ 100?
- Is InterCure in the Dow Jones?
- When was InterCure's last earnings report?
- When does InterCure report earnings?